Warfarin + Rucaparib Interaction
Moderateinteraction on record
Description
Concomitant administration with rucaparib can increase systemic exposure of warfarin, potentially increasing frequency or severity of adverse reactions. Consider increasing frequency of INR monitoring if concomitant use cannot be avoided.
Mechanism
CYP2C9 substrate; rucaparib inhibits CYP2C9
Source: NLP:rucaparib